Syrup
| S.NO | GENERIC NAME & DOSAGE FORM. | COMPOSITION |
|---|---|---|
| 1 | Dextromethorphan Hydrobromide, Chlorpheniramine Maleate & Menthol Syrup | Each 5ml contains: |
| Dextromethorphan Hydrobromide | ||
| Chlorpheniramine Maleate | ||
| Menthol | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 2 | Chlorpheniramine Maleate, Phenylephrine Hydrochloride & Dextromethorphan Hydrobromide Syrup | Each 5ml contains: |
| Chlorpheniramine Maleate | ||
| Phenylephrine Hydrochloride | ||
| Dextromethorphan Hydrobromide | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 3 | Terbutaline Sulphate, Bromhexine Hcl & Guaiphenesin Tablets | Each uncoated tablet contains: |
| Terbutaline Sulphate | ||
| Bromhexine Hcl | ||
| Guaiphenesin | ||
| Excipients | ||
| Approved colour used | ||
| 4 | Terbutaline Sulphate, Bromhexine Hcl, Guaiphenesin & Menthol Syrup | Each 10ml contains: |
| Terbutaline Sulphate | ||
| Bromhexine Hcl | ||
| Guaiphenesin | ||
| Menthol | ||
| Excipients | ||
| Approved colour used | ||
| 5 | Ferrous ascorbate & folic acid suspension | Each 5ml contains:- |
| Ferrous Ascorbate Eq. to Elemental Iron | ||
| Folic Acid | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 6 | Cyproheptadine Hydrochloride & Tricholine Citrate Syrup | Each 5 ml contains:- |
| Cyproheptadine Hydrochloride | ||
| Tricholine Citrate 65% | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 7 | Mefenamic Acid & Paracetamol Oral Suspension | Each 5 ml Contains:- |
| Mefenamic Acid | ||
| Paracetamol | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 8 | Citicoline Syrup | Each 5 ml Contains:- |
| Citicoline Sodium Eq. to Citicoline | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 9 | Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup | Each 5 ml Contains:- |
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 10 | Oxetacaine, Dried Aluminium Hydroxide Gel & Magnesium Hydroxide Oral suspension | Each 5 ml Contains:- |
| Oxetacaine | ||
| Dried Aluminium Hydroxide Gel | ||
| Magnesium Hydroxide | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 11 | Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Syrup | Each 5 ml Contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| Levosalbutamol Sulphate Eq. to Levosalbutamol | ||
| In a mentholated syrupy base | ||
| Approved colour used | ||
| 12 | Ambroxol Hydrochloride, Guaiphenesin, Terbutaline Sulphate & Menthol Syrup | Each 5 ml Contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| Terbutaline Sulphate | ||
| Menthol | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 13 | Ofloxacin Oral Suspension IP | Each 5 ml Contains: – |
| Ofloxacin | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 14 | Ofloxacin Oral Suspension IP | Each 5 ml Contains: – |
| Ofloxacin | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 15 | Sodium Picosulfate Oral Solution BP | Each 5 ml Contains: – |
| Sodium Picosulfate | ||
| In a sorbitol base | ||
| Approved colour used | ||
| 16 | Sucralfate &Oxetacaine Suspension | Each 10 ml contains: – |
| Sucralfate | ||
| Oxetacaine | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 17 | Magaldrate &Simethicone Suspension IP | Each 5 ml contains:- |
| Magaldrate (as anhydrous) | ||
| Simethicone | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 18 | Paracetamol Paediatric Oral Suspension IP | Each 5 ml contains:- |
| Paracetamol | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 19 | OndansetronOral solution IP | Each 5 ml contains:- |
| Ondansetron Hydrochloride Eq. to Ondansetron | ||
| In a flavoured solution base | ||
| Approved colour used | ||
| 20 | OndansetronOral solution IP | Each 5 ml contains:- |
| Ondansetron Hydrochloride Eq. to Ondansetron | ||
| In a flavoured solution base | ||
| Approved colour used | ||
| 21 | Azithromycin Oral Suspension IP | Each ml contains:- |
| Azithromycin Dihydrate Eq. to Azithromycin | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 22 | Paracetamol Paediatric Oral Suspension IP | Each 5 ml contains:- |
| Paracetamol | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 23 | Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride& Chlorpheniramine Maleate Syrup | Each 5 ml Contains:- |
| Dextromethorphan Hydrobromide | ||
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 24 | Mefenamic Acid & Paracetamol Oral Suspension | Each 5 ml Contains:- |
| Mefenamic Acid | ||
| Paracetamol | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 25 | Albendazole suspension IP 200 mg | Each 5 ml Contains:- |
| Albendazole | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 26 | Deflazacort oral suspension | Each 5 ml Contains:- |
| Deflazacort | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 27 | Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Syrup | Each 5 ml Contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| Terbutaline Sulphate | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 28 | Dried Aluminium Hydroxide Gel, Magnesium Hydroxide & Simethicone Suspension | Each 10 ml Contains:- |
| Dried Aluminium Hydroxide Gel Eq. to Aluminium Hydroxide | ||
| Magnesium Hydroxide | ||
| Activated Dimethiicone (Simethicone) | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 29 | Ofloxacin & Metronidazole Suspension | Each 5 ml contains:- |
| Ofloxacin | ||
| Metronidazole Benzoate Eq. to Metronidazole | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 30 | Elemental Calcium, Vitamin D3 & Cyanocobalamin Suspension | Each 10 ml contains:- |
| Calcium Carbonate (Oyster Shell) Eq. to Elemental Calcium | ||
| Vitamin D3 | ||
| Cyanocobalamin | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 31 | Levetiracetam Oral Solution IP | Each 5 ml contains:- |
| Levetiracetam | ||
| In a flavoured aquves vhecals base | ||
| Approved colour used | ||
| 32 | Levocloperastine Fendizoate Oral Suspension | Each 5 ml contains:- |
| Levocloperastine Fendizoate Eq. to Levocloperastine Hydrochloride | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 33 | Levodropropizine & Chlorpheniramine Syrup | Each 5 ml contains:- |
| Levodropropizine | ||
| Chlorpheniramine Maleate | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 34 | Phenylephrine Hydrochloride, Chlorpheniramin e Maleate, Sodium Citrate & Menthol Syrup | Each 5 ml contains:- |
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| Sodium Citrate | ||
| Menthol | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 35 | Salbutamol & Etofylline Syrup | Each 5 ml contains:- |
| Salbutamol Sulphate Eq. to Salbutamol | ||
| Etofylline | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 36 | Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Maleate, Sodium Citrate , Ammonium Chloride & Menthol Suspension | Each 5 ml contains:- |
| Paracetamol | ||
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| Sodium Citrate | ||
| Ammonium Chloride | ||
| Menthol | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 37 | Ambroxol Hydrochloride & Guaiphenesin Syrup | Each 5 ml contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 38 | Ambroxol Hydrochloride & Cetirizine Hydrochloride Syrup | Each 5 ml contains:- |
| Ambroxol Hydrochloride | ||
| Cetirizine Hydrochloride | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 39 | Dicyclomine Hydrochloride & Activated Dimethicone oral Suspension | Each 5 ml contains:- |
| Dicyclomine Hydrochloride | ||
| Activated Dimethicone | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 40 | Magaldrate, Simethicone & Oxetacaine Suspension | Each 5 ml contains:- |
| Magaldrate (as anhydrous) | ||
| Simethicone | ||
| Oxetacaine | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 41 | Cyanocobalamin, Folic Acid & Niacinamide oral Drops | Each 5ml contains:- |
| Cyanocobalamin (Anhydrous) | ||
| Folic Acid | ||
| Niacinamide | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 42 | Potassium Citrate & Citric Acid oral Solution USP | Each 5 ml contains:- |
| Potassium Citrate Monohydrate | ||
| Citric Acid Monohydrate | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 43 | Iron (III) Hydroxide Polymaltose & Folic Acid Oral Drops | Each ml contains:- |
| Iron (III) Hydroxide Polymaltose Complex Eq. to Elemental Iron | ||
| Folic Acid | ||
| In a flavoured base | ||
| Approved colour used | ||
| 44 | Dicyclomine Hydrochloride & Simethicone oral Drops | Each ml contains:- |
| Dicyclomine Hydrochloride | ||
| Simethicone Emulsion Eq. to Simethicone | ||
| In a flavoured base | ||
| Approved colour used | ||
| 45 | Ambroxol Hydrochloride, Guaiphenesin & Terbutaline Sulphate Drops | Each ml Contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| Terbutaline Sulphate | ||
| In a mentholated syrupy base | ||
| Approved colour used | ||
| 46 | Levocetirizine Dihydrochloride Syrup IP | Each 5ml contains:- |
| Levocetirizine Dihydrochloride | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 47 | Calcium & Vitamin D3 Suspension | Each 5ml contains:- |
| Calcium Carbonate Eq. to elemental Calcium From an Organic source (Oyster Shells) | ||
| Vitamin D3 | ||
| In a flavoured Suspension base | ||
| Approved colour used | ||
| 48 | Phenylephrine Hydrochloride & Chlorpheniramin e Maleate Syrup | Each 5ml contains:- |
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| In a flavoured Syrupy base | ||
| Approved colour used | ||
| 49 | Liquid Paraffin, Milk of Magnesia & Sodium Picosulfate Suspension | Each 5ml contains:- |
| Liquid Paraffin | ||
| Milk of Magnesia | ||
| Sodium Picosulfate | ||
| In a flavoured Sorbitol base | ||
| Approved colour used | ||
| 50 | Magaldrate, Simethicone & Oxetacaine Suspension | Each 5 ml contains:- |
| Magaldrate (as anhydrous) | ||
| Simethicone | ||
| Oxetacaine | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 51 | Cyproheptadine Hydrochloride & Tricholine Citrate oral Drops | Each ml contains:- |
| Cyproheptadine Hydrochloride (as anhydrous) | ||
| Tricholine Citrate 65% | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 52 | Albendazole & Ivermectin oral Suspension | Each 5 ml Contains:- |
| Albendazole | ||
| Ivermectin | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 53 | Ferric Ammonium Citrate, Folic Acid & Cyanocobalamin Syrup | Each 15 ml Contains:- |
| Ferric Ammonium Citrate | ||
| Folic Acid | ||
| Cyanocobalamin | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 54 | Potassium Chloride Oral Solution USP 20% | Each 15 ml contains:- |
| Potassium Chloride | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 55 | Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Syrup | Each 5 ml contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| Levosalbutamol Sulphate Eq. to Levosalbutamol | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 56 | Ambroxol Hydrochloride, Guaiphenesin & Levosalbutamol Syrup | Each 5 ml contains:- |
| Ambroxol Hydrochloride | ||
| Guaiphenesin | ||
| Levosalbutamol Sulphate Eq. to Levosalbutamol | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 57 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension | Each 5 ml contains:- |
| Paracetamol | ||
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 58 | Levocetirizine Dihydrochloride & Montelukast Syrup | Each 5 ml contains:- |
| Levocetirizine Dihydrochloride | ||
| Montelukast Sodium Eq. to Montelukast | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 59 | Magaldrate & Simethicone Suspension IP | Each 10 ml contains:- |
| Magaldrate (as anhydrous) | ||
| Simethicone | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 60 | Vitamin D3 Oral Solution 60000 IU | Each 5 ml contains:- |
| Cholecalciferol Concentrate (as Stabilized) Eq. to Cholecalciferol (Vitamin D3) (In Nano Droplet From) | ||
| In a flavoured Sorbitol (70%) base (Non Crystallising) | ||
| 61 | Ibuprofen & Paracetamol Suspension | Each 5 ml contains:- |
| Ibuprofen | ||
| Paracetamol | ||
| In a flavoured suspension base | ||
| Approved colour used | ||
| 62 | Magaldrate & Simethicone Suspension IP | Each 10 ml contains:- |
| Magaldrate (as anhydrous) | ||
| Simethicone | ||
| Sorbitol Solution (70%) (non-crystallising) | ||
| Approved colour used | ||
| 63 | Aceclofenac & Paracetamol Suspension | Each 5ml contains:- |
| Aceclofenac | ||
| Paracetamol | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 64 | Cyproheptadine Hydrochloride & Tricholine Citrate Syrup | Each 5 ml contains:- |
| Cyproheptadine Hydrochloride Eq. to Anhydrous Cyproheptadine Hydrochloride | ||
| Tricholine Citrate 65% | ||
| In a flavoured sorbitol (70%) base (Non-Crystallising) | ||
| Approved colour used | ||
| 65 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains:- |
| Disodium Hydrogen Citrate | ||
| In a flavoured syrupy base | ||
| Approved colour used | ||
| 66 | Lactulose Oral Solution USP | Each 15 ml contains:- |
| Lactulose Concentrate Eq. to Lactulose | ||
| Palatable base | ||
| Approved colour used | ||
| 67 | Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Oral Drops | Each 1 ml contains:- |
| Paracetamol | ||
| Phenylephrine Hydrochloride | ||
| Chlorpheniramine Maleate | ||
| In a flavoured syrupy base |